Overview
Treatment of Chronic Anemia With Epoetin Alfa in Elderly
Status:
Unknown status
Unknown status
Trial end date:
2005-07-01
2005-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine if chronic anemia can be corrected with epoetin alfa and does the subsequent correction lead to an improvement in fatigue,quality of life or mobility among elderly.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Research and Education Foundation of Michael Reese HospitalCollaborators:
John H. Stroger Hospital
Mercy Hospital and Medical Center, Illinois
Ortho Biotech Clinical Affairs, L.L.C.Treatments:
Epoetin Alfa
Criteria
Inclusion Criteria:- 65 years of age or older Diagnosed with chronic anemia Hemoglobin level less than or
equal to 11.5 g/dl Community dwelling Able to make monthly clinic visits
Exclusion Criteria:
- Currently on Epoetin alfa or similar preparations Having nutritional anemia Having
active cancer or received recent treatment for cancer On treatment for Kidney disease
Diagnosis of dementia Inability to ambulate